Tag: German

Embark on an illuminating expedition into the heart of Germany’s pharmaceutical landscape! Join host Stefan Walzer and esteemed guest Matthias Flume, pharmacist and leader of a regional physicians association, as they delve into the transformative world of the AMNOG (Arzneimittelmarktneuordnungsgesetz) 2.0 reforms, spotlighting the pivotal 2023 updates.

Prepare to be engrossed by a narrative that not only scrutinizes the current state of pharmaceutical regulations but also ventures into speculative territory regarding future shifts. Tune in to gain valuable insights into the evolving dynamics of healthcare in Germany!

Listen to the podcast: here

Dive into the complex world of healthcare reimbursement in Germany with this podcast episode, where the market access expert, Dr. Stefan Walzer, unlocks the intricacies of evaluating and integrating new diagnostic methods into the outpatient reimbursement catalogue. Join us as we explore the critical requirements for assessment, the pivotal role of the evaluation committee, a sub-committee of the German Federal Committee (G-BA), and the nuanced process of price setting in this unique healthcare landscape.

In an enlightening conversation with Prof. Jürgen Wasem, the Head of the arbitration board for the evaluation committee, we peel back the layers of this rigorous evaluation process, offering listeners an exclusive look at the inner workings of healthcare reimbursement decisions and the strategic considerations behind them.

Listen to the podcast: here

Dive into the heart of Germany’s AMNOG process in this podcast episode, where the intersection of law and market access unfolds. Join Dr. Stefan Walzer, an AMNOG expert, and Alexander Meier, an experienced market access lawyer, as they explore the pivotal role of legal expertise in navigating the complexities of introducing innovative drugs in Germany. This engaging discussion sheds light on the crucial contributions of lawyers, from shaping negotiation strategies to finalizing legal contracts at the conclusion of the AMNOG process.

Discover the synergy between law and market access, and how this collaboration is instrumental in the successful launch of new drugs. Whether you’re a professional in the pharmaceutical industry or just fascinated by the interplay of law and healthcare, this episode offers unique insights into the AMNOG process and the role of legal professionals.

Listen to the podcast: here

Unlock the secrets to healthcare innovation in this podcast episode as Dr. Stefan Walzer and Dr. Sebastian Casu, a renowned medical doctor and influencer, delve into the pivotal role of NUBs, OPS, and DRG values in patient care. Wondering how groundbreaking innovations bypass administrative hurdles to reach those in need? Or what the future holds for digital health care in Germany? Our experts continue the riveting discussion from Episode 9, featuring insights from Willi Wöllner, to explore the cutting-edge of inpatient market access and digital healthcare advancements. Don’t let this conversation pass you by – tune in now for a deep dive into bedside innovation and the digital transformation of healthcare. Be part of the forefront of market access dialogue with MArS, the first and only bi-weekly podcast dedicated to market access insights.

Listen to the podcast: here

Dive into the intricate world of reimbursement within the German hospital setting with Dr. Stefan Walzer and experienced hospital administrator Willi Wöllner as they unravel the complexities of inpatient care negotiations. Ever wondered how hospitals and health insurance funds hash out annual budgets? Or what a NUB is and its significance in these discussions? Perhaps you’re curious if industry really can take part in this process. Our experts are peeling back the layers of the business side of hospital operations, setting the stage for an enlightening follow-up on the medical perspective with Dr. Sebastian Casu in the next episode. Don’t miss this insightful journey into the heart of healthcare financing. Subscribe now on your favorite podcast platform and connect with the cutting-edge insights from MArS Market Access and Pricing Strategy.

Listen to the podcast: here

Step into the high-stakes world of healthcare negotiations in this podcast episode, where Dr. Stefan Walzer, together with negotiation expert and lawyer Bibiane Schulte-Bosse, unravels the intricate dance of price negotiations within the AMNOG process. This episode offers a deep dive into the critical negotiation phase of AMNOG, shedding light on strategies and insights that define the outcome of healthcare product market access in Germany. Curious about the behind-the-scenes of healthcare negotiations? Have questions you’re burning to ask? Join us for a riveting exploration of the AMNOG negotiations. Subscribe on your favorite podcasting platform to never miss an insight!

Listen to the podcast: here

Join Dr. Stefan Walzer as he delves into the transformative world of digital health with a critical look at the first year of DIGAs. Is the “fast track process” for digital health applications truly making waves in healthcare innovation? This episode brings in the expertise of two digital health luminaries, Prof. Dr. David Matusiewicz of FOM University and Dr. Anne Sophie Geier from the head association of digital healthcare SVDGV, to dissect the current state of digitalization in the German healthcare system. Engage with the forefront of digital healthcare discussions and stay ahead of the curve. Don’t miss out on this opportunity to connect with the digital pulse of healthcare. Subscribe to our podcast on your favorite platform and be part of the conversation shaping the future of health.

Listen to the podcast: here